Researchers at the Geisinger Health System have developed a simple scoring system (DiaRem) that may help predict which candidates for gastric bypass surgery are likely to achieve type 2 diabetes remission within five years.  Roux-en-Y gastric bypass (RYGB) is currently used to help morbidly obese patients lose weight. 

However, type 2 diabetes fails to resolve or improve in approximately 40% of patients.

John Schieszer reports in today’s Medical Minute that a new scoring system may provide a scientifically valid way to help physicians assess the likelihood of diabetes remission after RYGB surgery.

Continue Reading

Topics:

Diabetes